This possibility is supported by numerous reports reveling PAD4-mediated citrullination in various neuropathological conditions, such as multiple sclerosis (Sarswat et al. 2017), Alzheimer’s disease (Ishigami et al. 2005), and cerebral ischemia (Seol et al. 2024). This evidence concerns the gene PADI4 and Cerebral ischemia.